Yes, we could have up to 60 centres across US and Europe. The majority will be done through Clevland but as long as at least one is done in other centres (often where our Ad Board members work) they can then potentially (if we get approval) continue to use the valve if they and the patient wish.
I would expect the income to be the same as what we get reimbursed for the trial.
AVR Price at posting:
$19.05 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)